Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

Phase 4

Completed

• Conditions: Cataract; Dry Eye

• Registration Number: NCT00349583
• Lead Sponsor: Innovative Medical

Brief Summary

The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-07-05
• Study First Submitted QC: 2006-07-05
• Study First Posted: 2006-07-07
• Status Verified: 2007-05
• Last Update Submitted: 2007-05-30
• Last Update Posted: 2007-06-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• · Males or females > 50 years old

  • Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
  • Likely to complete all study visits and able to provide informed consent
  • Visual potential of 20/25 or better

Exclusion Criteria

• · Prior use of topical cyclosporine

  • Known contraindications to any study medication or ingredients
  • Active ocular diseases or uncontrolled systemic disease
  • Active ocular allergies

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Ophthalmic Consultants of Long Island; 🇺🇸 Rockville Centre, New York, United States